Division of Hematology/Oncology, University of Cincinnati, Cincinnati, OH, USA.
Division of Hematology/Oncology, University of Cincinnati, Cincinnati, OH, USA; Medical Scientist Training Program, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA.
Cell Rep. 2018 Aug 28;24(9):2404-2417.e8. doi: 10.1016/j.celrep.2018.07.101.
Cells adapt to nutrient and energy deprivation by inducing autophagy, which is regulated by the mammalian target of rapamycin (mTOR) and AMP-activated protein kinases (AMPKs). We found that cell metabolism significantly influences the ability to induce autophagy, with mitochondrial complex I function being an important factor in the initiation, amplitude, and duration of the response. We show that phenformin or genetic defects in complex I suppressed autophagy induced by mTOR inhibitors, whereas autophagy was enhanced by strategies that increased mitochondrial metabolism. We report that mTOR inhibitors significantly increased select phospholipids and mitochondrial-associated membranes (MAMs) in a complex I-dependent manner. We attribute the complex I autophagy defect to the inability to increase MAMs, limiting phosphatidylserine decarboxylase (PISD) activity and mitochondrial phosphatidylethanolamine (mtPE), which support autophagy. Our data reveal the dynamic and metabolic regulation of autophagy.
细胞通过诱导自噬来适应营养和能量的缺乏,而自噬受哺乳动物雷帕霉素靶蛋白 (mTOR) 和 AMP 激活的蛋白激酶 (AMPK) 的调节。我们发现细胞代谢会显著影响诱导自噬的能力,其中线粒体复合物 I 的功能是启动、幅度和反应持续时间的重要因素。我们表明,二甲双胍或复合物 I 的遗传缺陷抑制了由 mTOR 抑制剂诱导的自噬,而通过增加线粒体代谢的策略则增强了自噬。我们报告说,mTOR 抑制剂以复合物 I 依赖性的方式显著增加了特定的磷脂和线粒体相关膜 (MAMs)。我们将复合物 I 的自噬缺陷归因于无法增加 MAMs,从而限制了磷酸丝氨酸脱羧酶 (PISD) 活性和支持自噬的线粒体磷脂酰乙醇胺 (mtPE)。我们的数据揭示了自噬的动态和代谢调节。